Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact

Area of Science:

• Pulmonary Medicine
• Hematology

Background:

• Chronic obstructive pulmonary disease (COPD) is a prevalent, preventable, and treatable respiratory condition with significant global impact.
• COPD is linked to increased morbidity and mortality, with comorbidities significantly worsening patient outcomes.
• Common COPD comorbidities include cardiac diseases, lung cancer, osteoporosis, and depression.

Purpose of the Study:

• To highlight anemia as a recently recognized and frequent comorbidity in COPD patients.
• To discuss the prevalence and likely type of anemia associated with COPD.
• To outline the negative impact of anemia on COPD patients' health outcomes and healthcare utilization.

Main Methods:

• Literature review and synthesis of current understanding regarding anemia in COPD.
• Analysis of reported prevalence rates of anemia in COPD populations.
• Examination of the relationship between anemia and COPD-mediated systemic inflammation, specifically Anemia of Chronic Disease (ACD).

Main Results:

• Anemia affects 7.5% to 33% of COPD patients, with Anemia of Chronic Disease (ACD) being the most common type.
• ACD in COPD is primarily driven by systemic inflammation associated with the disease.
• Anemia in COPD patients is associated with increased healthcare utilization, poorer quality of life, reduced survival, and higher hospitalization rates.

Conclusions:

• Anemia is a significant comorbidity in COPD with detrimental effects on patient prognosis.
• Systemic inflammation in COPD likely contributes to the development of ACD.
• Further large-scale prospective studies are required to fully elucidate the association between anemia and COPD.